Croteau, David
United States Food and Drug Administration · Center for Drug Evaluation and Research
3 papers on CoChatORCID 0000-0002-5561-6940
Most cited papers
- Verified
Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group
Kunwar, S., Prados, M. D., Chang, S. M., Berger, M. S., Lang, F. F., Piepmeier, J. M., Sampson, J. H., Ram, Z., Gutin, P. H., Gibbons, R. D., et al. (2007) · Journal of Clinical Oncology
Glioma Diagnosis and TreatmentToxin Mechanisms and Immunotoxins
Cited by 325
- Verified
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death
Harbourt, K., Nevo, O. N., Zhang, R., Chan, V., & Croteau, D. (2020) · Pharmacoepidemiology and Drug Safety
Pharmacovigilance and Adverse Drug ReactionsSleep and related disorders
Cited by 46
- Verified
Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder
Mooney, L. J., Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., et al. (2016) · Journal of Addiction Medicine
Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free